The SaaS startup ecosystem is experiencing renewed vitality, as two funding rounds announced today demonstrate. While artificial intelligence dominates headlines, companies like H1 and Corgi prove that a solid business model and proprietary data can still attract billions in capital. The most emblematic case is H1, a healthcare data platform, which secured a $40 million investment from CVS Health. CEO Ariel Katz emphasized that AI can replicate workflow automation, but it cannot copy H1's unique repository of clinical information. This reinforces the idea that competitive advantage lies in data quality, not just algorithms.
The Corgi case: valuation doubled in three weeks
Even more surprising is the story of Corgi, a startup that announced a $106 million round at a $2.6 billion valuation, doubling its worth in just three weeks. This came right after closing a $160 million round. While back-to-back rounds with steep step-ups have become almost routine in Silicon Valley, a doubling in such a short time raises questions, especially since the investor set in both rounds is the same. This dynamic suggests very strong demand for scalable SaaS solutions, but also possible valuation bubbles. In a market where generative AI seems to dominate, Corgi shows that traditional software subscription models can still generate excitement.
The context: AI vs SaaS, a false dichotomy
One should not think of a sharp contrast. As we analyzed in a previous article, 2026 is redefining artificial intelligence amidst challenges and opportunities, but the H1 and Corgi cases show that traditional SaaS is far from dead. In fact, the ability to integrate AI features within established platforms could be the key to future success. Platforms like H1 build a moat based on unique data, a concept well known in the software as a service world, as described on Wikipedia. The advantage lies in being indispensable to customers, regardless of the current trend.
Implications for startups and investors
These two rounds send a clear signal: investors are willing to bet on companies with proven business models, as long as they have a defensible advantage. H1 has physician data, Corgi likely has a logistics or insurance platform that scales quickly. For growth-stage startups, the message is that you don't need to chase AI at all costs: if your product solves a real problem with exclusive data, capital will follow. For investors, however, Corgi's valuation doubling must prompt reflection on the sustainability of certain estimates, in a market that remains hot but not risk-free.
Ultimately, 2026 confirms itself as a year of dualism: on one hand the explosion of generative AI, on the other a renewed confidence in vertical SaaS. H1 and Corgi are just the first examples of a trend that could redefine venture capital priorities in the coming months.
Sponsored Protocol
